180 life sciences corp. announces pricing of $2.9 million registered direct offering and concurrent private placement priced at-the-market under nasdaq rules

Palo alto, ca / accesswire / december 27, 2024 / 180 life sciences corp. ("180" or the "company") (nasdaq:atnf), a biotechnology company that is currently refocusing its business on the international entertainment and igaming sector, today announced that it has entered into a securities purchase agreement with several institutional investors to sell 1,200,000 shares of common stock in a registered direct offering priced at market under nasdaq rules. in a concurrent private placement, the company also agreed to issue unregistered warrants to purchase up to an aggregate of 1,200,000 shares of common stock.
ETHZ Ratings Summary
ETHZ Quant Ranking